Patients with elevated IGF-1 were younger, were more likely to be male and Black, had lower eGFR at baseline, and had a longer duration of type 2 diabetes compared to patients with lower concentrations of the biomarker (Additional file 1: Table S5). Here, IGF1 is linked to type 2 diabetes mellitus.